Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Cattaneo

Showing results (41-50 of 263) with videos related to

Pageof 27
Sort By:
Giornale Italiano Di Cardiologia (2006)|August 2, 2013
[The ARCTIC study]Marco Cattaneo, Filippo Ottani
Journal of Cardiovascular Development and Disease|April 27, 2023
Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative ReviewBianca Clerici, Marco Cattaneo
Soft Matter|July 25, 2023
Shell viscosity estimation of lipid-coated microbubblesMarco Cattaneo, Outi Supponen
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 16, 2017
Hemostasis and HemotherapyWolfgang Korte, Marco Cattaneo
Blood Transfusion = Trasfusione Del Sangue|May 27, 2020
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trialMarco Cattaneo, Nuccia Morici
Circulation|May 23, 2018
Letter by Cattaneo and von Kügelgen Regarding Article, "International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor-Inhibiting Therapies"Marco Cattaneo, Ivar von Kügelgen
Internal and Emergency Medicine|February 24, 2010
State of the art of new P2Y12 antagonistsMarco Cattaneo, Gian Marco Podda
Thrombosis and Haemostasis|March 31, 2017
High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMIGian Marco Podda, Marco Cattaneo
Thrombosis and Haemostasis|October 17, 2012
Why does ticagrelor induce dyspnea?Marco Cattaneo, Elena M Faioni
Journal of the American College of Cardiology|April 29, 2014
Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevanceMarco Cattaneo, Rainer Schulz, Sven Nylander
Pageof 27

Showing results (41-50 of 263) with videos related to

Sort By:
Pageof 27
Giornale Italiano Di Cardiologia (2006)|August 2, 2013
[The ARCTIC study]Marco Cattaneo, Filippo Ottani
Journal of Cardiovascular Development and Disease|April 27, 2023
Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative ReviewBianca Clerici, Marco Cattaneo
Soft Matter|July 25, 2023
Shell viscosity estimation of lipid-coated microbubblesMarco Cattaneo, Outi Supponen
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 16, 2017
Hemostasis and HemotherapyWolfgang Korte, Marco Cattaneo
Blood Transfusion = Trasfusione Del Sangue|May 27, 2020
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trialMarco Cattaneo, Nuccia Morici
Circulation|May 23, 2018
Letter by Cattaneo and von Kügelgen Regarding Article, "International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor-Inhibiting Therapies"Marco Cattaneo, Ivar von Kügelgen
Internal and Emergency Medicine|February 24, 2010
State of the art of new P2Y12 antagonistsMarco Cattaneo, Gian Marco Podda
Thrombosis and Haemostasis|March 31, 2017
High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMIGian Marco Podda, Marco Cattaneo
Thrombosis and Haemostasis|October 17, 2012
Why does ticagrelor induce dyspnea?Marco Cattaneo, Elena M Faioni
Journal of the American College of Cardiology|April 29, 2014
Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevanceMarco Cattaneo, Rainer Schulz, Sven Nylander
Pageof 27